Status:
COMPLETED
Right Colon Polyp Miss Rates of Water Exchange and Carbon Dioxide Insufflation Colonoscopy
Lead Sponsor:
Evergreen General Hospital, Taiwan
Conditions:
Right Colon Adenoma Miss Rate
Right Colon Hyperplastic Polyp Miss Rate
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
This will be a prospective randomized controlled trial comparing CO2 insufflation and WE in terms of right colon combined adenoma miss rate (AMR) and hyperplastic polyp miss rate (HPMR) by tandem insp...
Detailed Description
This will be a prospective RCT comparing CO2 insufflation and WE in terms of right colon combined AMR and HPMR by tandem inspection. It is originally designed as a multicenter study conducted in three...
Eligibility Criteria
Inclusion
- Consecutive patients aged 45 years or older undergoing colonoscopy for screening, surveillance, and positive FIT will be considered for enrollment.
Exclusion
- familial adenomatous polyposis and hereditary non-polyposis CRC syndrome, personal history of CRC or inflammatory bowel disease, previous colonic resection, obstructive lesions of the colon, gastrointestinal bleeding, allergy to fentanyl, midazolam or propofol, American Society of Anesthesiology (ASA) classification of physical status grade 3 or higher, mental retardation, pregnancy, and refusal to provide a written informed consent.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2019
Estimated Enrollment :
262 Patients enrolled
Trial Details
Trial ID
NCT03845933
Start Date
April 1 2019
End Date
October 31 2019
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evergreen General Hospital
Taoyuan District, Taiwan